Cover design by Ankit Kankar · 52 pages including cover
Move your pointer across the cover
New issue Volume 21 / Issue 10 / October 2026 / Asia Edition
From symptom control to disease modification. Can precision biology, new modalities, blood-brain barrier technologies and better measurement turn neurology’s breakthroughs into a repeatable model?
Cover story by Ayesha Siddiqui · pages 13 to 29
Filter by desk, search the full text of every article, or read the contents the way it is printed.
The executives, analysts and editors on the record this month. Select any one to open their piece.
The money that came back to CNS, and the late-stage programmes now carrying the argument.
Across 2024 and 2025, 24 neurology M&A transactions carried a combined value of $26.9 billion. Neurology M&A activity rose from 10 deals in 2024 to 14 in 2025, and the global CNS market was projected to pass $80 billion in sales in 2025 for the first time since 2013.
All 52 pages exactly as they went to press, each one indexed. Use the arrow keys, or select a page to enlarge it.
